StockData
Atrium Therapeutics, Inc. logo

Atrium Therapeutics, Inc. (RNA) stock

RNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$6.64+0.16 (+2.47%)

Close on Nov 18, 2026Market cap $113.58MP/E –Yield –

Atrium Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-27.8%+306.9
Q2 FY2026Jun 30, 2026-672.0%−198.4
Q1 FY2026Mar 31, 2026-84.7%–
Q3 FY2025Sep 30, 2025-0.3%–
Q2 FY2025Jun 30, 2025-334.8%–
Q1 FY2025Mar 31, 2025-473.6%–

More Atrium Therapeutics figures

See a number that looks wrong?